Philips details plans to increase its hospital ventilator production

Posted by CPAP Indo

April 15, 2020

Philips details plans to increase its hospital ventilator production to 4,000 units/week by Q3 2020, and introduces its new Philips Respironics E30 ventilator with an immediate production of 15,000 units/week

Philips engages manufacturing partners Flex Ltd. (NASDAQ: FLEX) and Jabil (NYSE: JBL), as well as other partners, to further expand its hospital ventilator assembly lines and strengthen its supply chain
Company introduces the Philips Respironics E30 ventilator, a versatile and easy-to-use ventilator to treat patients with respiratory insufficiency, designed for large scale production
FDA authorized the Philips Respironics E30 ventilator for use in the US during the COVID-19 public health emergency through its EUA process on April 8, 2020; Philips is working with the relevant regulatory authorities to also distribute the device globally
Philips continues to work with its global suppliers to ensure a sufficient and uninterrupted supply of components. This is the rate-limiting step, and requires the support of all countries involved

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today provided an update on its plans to double the production of its hospital ventilators by May 2020 and achieve a four-fold increase by the third quarter of 2020. This plan builds on Philips’ initial production increase in the first three months of the year, which already enabled the supply of additional ventilators – that are critical for the treatment of COVID-19 patients – to hospitals in the most affected regions in China, southern Europe and the US. To further address the huge global demand, Philips introduced its new Philips Respironics E30 ventilator, a versatile and easy-to-use non-invasive and invasive ventilator, which has been designed for large scale production.

← Older Post